Overview

The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The objective of this survey is to confirm the safety of Suglat Tablets when used in the elderly.
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin